[AstraZeneca's breast cancer treatment trial did not meet expectations] AstraZeneca announced that the experimental anti-cancer drug Dato DXD, which was jointly developed with Daiichi Sankyo, failed ...

[AstraZeneca's "breast cancer ADC miracle drug" DS-8201 entered the new version of the medical insurance directory] According to the 2024 national medical insurance directory released today, the repo ...